CYTK (STOCKS)
Cytokinetics Inc.
$73.450000
-2.190000 (-2.90%)
Prev close: $75.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert I. Blum
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,208.46M
- Employees
- 498
- P/E (TTM)
- -10.47
- P/B (TTM)
- -60.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
19
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.50 | $-1.67 | +0.1732 | +10.35% |
|
Mar 2026 (Q1)
|
$-1.67 | $-1.69 | +0.0159 | +0.94% |
|
Dec 2025 (Q4)
|
$-1.50 | $-1.49 | -0.0144 | -0.97% |
|
Sep 2025 (Q3)
|
$-2.55 | $-1.61 | -0.9385 | -58.24% |
Financial Statements
| Revenues | $67.67M |
| Benefits Costs and Expenses | $426.17M |
| Costs And Expenses | $802.66M |
| Nonoperating Income/Loss | $46.68M |
| Operating Expenses | $775.58M |
| Research and Development | $396.96M |
| Other Operating Expenses | $169.33M |
| Operating Income/Loss | -$707.91M |
| Income/Loss From Continuing Operations After Tax | -$894.00M |
| Income/Loss From Continuing Operations Before Tax | -$585.89M |
| Net Income/Loss | -$894.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$894.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$894.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.22 |
| Diluted Earnings Per Share | -$7.22 |
| Basic Average Shares | 248,472 |
| Diluted Average Shares | 376,127 |
| Assets | $1.92B |
| Current Assets | $1.21B |
| Cash | $1.70B |
| Inventory | $380.00K |
| Noncurrent Assets | $716.06M |
| Fixed Assets | $78.92M |
| Other Non-current Assets | $637.15M |
| Liabilities | $2.10B |
| Current Liabilities | $181.43M |
| Accounts Payable | $20.51M |
| Wages | $34.34M |
| Other Current Liabilities | $126.58M |
| Noncurrent Liabilities | $1.92B |
| Equity | -$173.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$173.49M |
| Liabilities And Equity | $1.92B |
| Net Cash Flow From Operating Activities | -$555.45M |
| Net Cash Flow From Operating Activities, Continuing | -$555.45M |
| Net Cash Flow From Investing Activities | -$503.68M |
| Net Cash Flow From Investing Activities, Continuing | -$503.68M |
| Net Cash Flow From Financing Activities | $1.24B |
| Net Cash Flow From Financing Activities, Continuing | $1.24B |
| Exchange Gains/Losses | -$841.00K |
| Net Cash Flow | $181.83M |
| Net Cash Flow, Continuing | $182.67M |
| Comprehensive Income/Loss | -$897.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$897.67M |
| Other Comprehensive Income/Loss | -$309.85M |